Cumberland Pharmaceuticals to Announce 2011 Year End Financial Results on February 29, 2012
Cumberland Pharmaceuticals to Announce 2011 Year End Financial Results on February 29,... -- NASHVILLE, Tenn., Feb. 8, 2012 /PRNewswire/ --
Cumberland Pharmaceuticals to Announce 2011 Year End Financial Results on February 29, 2012
NASHVILLE, Tenn., Feb. 8, 2012 /PRNewswire/ -- Cumberland Pharmaceuticals Inc. (NASDAQ: [ CPIX ]) announced today that it will release 2011 year-end financial results after the market closes on Wednesday, February 29, 2012. A conference call and live Internet webcast will be held on Wednesday, February 29, 2012, at 5:00 p.m. Eastern Time to discuss the results.
To participate in the call, please dial 877-303-1298 (for U.S. callers) or 253-237-1032 (for international callers). A rebroadcast of the teleconference will be available for one week and can be accessed by dialing 855-859-2056 (for U.S. callers) or 404-537-3406 (for international callers). The Conference ID for the rebroadcast is 50392851. The live webcast and rebroadcast can be accessed via Cumberland's website at [ http://investor.shareholder.com/cpix/events.cfm ].
Cumberland Pharmaceuticals Inc. is a specialty pharmaceutical company focused on the acquisition, development and commercialization of branded prescription products. The Company's primary target markets include hospital acute care and gastroenterology. Cumberland's marketed products include Acetadote® (acetylcysteine) Injection for the treatment of acetaminophen poisoning, Caldolor® (ibuprofen) Injection, the first injectable treatment for pain and fever approved in the United States, and Kristalose® (lactulose) for Oral Solution, a prescription laxative. Cumberland is dedicated to providing innovative products that improve quality of care for patients. For more information on Cumberland, please visit the Company's website at [ www.cumberlandpharma.com ].
SOURCE Cumberland Pharmaceuticals Inc.
[ Back to top ] RELATED LINKS
[ http://www.cumberlandpharma.com ]